Los Angeles Capital Management
CATX icon

Los Angeles Capital Management’s Perspective Therapeutics CATX Stock Holding History

Los Angeles Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,595
Closed -$60.4K – 2506
2025
Q3 		$60.4K Hold
17,595
– – ﹤0.01% 1336
2025
Q2 		$60.5K Buy
+17,595
New +$46.5K ﹤0.01% 1290
2025
Q1 		– Sell
-11,424
Closed -$36.4K – 1099
2024
Q4 		$36.4K Hold
11,424
– – ﹤0.01% 1097
2024
Q3 		$153K Buy
+11,424
New +$152K ﹤0.01% 1136

Other funds holding CATX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Los Angeles Capital Management's CATX Position: Q4 2025 in Review

Los Angeles Capital Management sold out of Perspective Therapeutics (CATX) in Q4 2025, closing a stake of 17,595 shares — an estimated $60.4K sold.

Los Angeles Capital Management first reported a position in CATX in Q3 2024 and held it in 4 quarters. The position peaked at $153K in Q3 2024. 117 funds tracked by Wall St. Rank hold CATX as of Q4 2025.

  • Los Angeles Capital Management reported no remaining Perspective Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 17,595 Perspective Therapeutics shares in Q4 2025, an estimated $60.4K.
  • Los Angeles Capital Management first reported a position in Perspective Therapeutics in Q3 2024 and held it in 4 quarters.
  • Los Angeles Capital Management's Perspective Therapeutics position peaked at $153K in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2025.

Based on Los Angeles Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.